Publications by authors named "Magnus Brisander"

Claim this Profile
S
Severe Impact of Omeprazole Timing on pH-Sensitive Dasatinib Absorption: Unveiling Substantial Drug-Drug Interaction.
Per Andersson, Magnus Brisander, Charlotta Liljebris, Gérald Jesson, Hans Lennernäs

J Clin Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Bioavailability and Reduced Variability of Dasatinib and Sorafenib with a Novel Amorphous Solid Dispersion Technology Platform.
Hans Lennernäs, Magnus Brisander, Charlotta Liljebris, Gérald Jesson, Per Andersson

Clin Pharmacol Drug Dev· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Despite warnings, co-medication with proton pump inhibitors and dasatinib is common in chronic myeloid leukemia, but XS004, a novel oral dasatinib formulation, provides reduced pH-dependence, minimizing undesirable drug-drug interactions.
Gunnar Larfors, Per Andersson, Gérald Jesson, Charlotta Liljebris, Magnus Brisander

Eur J Haematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrix effects in nilotinib formulations with pH-responsive polymer produced by carbon dioxide-mediated precipitation.
Stefano Colombo, Magnus Brisander, Jakob Haglöf, Peter Sjövall, Per Andersson

Int J Pharm· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbon dioxide-mediated generation of hybrid nanoparticles for improved bioavailability of protein kinase inhibitors.
Gérald Jesson, Magnus Brisander, Per Andersson, Mustafa Demirbüker, Helene Derand

Pharm Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical characterization of anhydrous and hydrous forms of the hydrochloride salt of BVT.5182 a novel 5-HT(6) receptor antagonist.
Andreas Hugerth, Magnus Brisander, Ulla Wrange, Mikael Kritikos, Björn Norrlind

Drug Dev Ind Pharm· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diastereoselective reduction of a chiral N-Boc-protected delta-amino-alpha,beta-unsaturated gamma-keto ester Phe-Gly dipeptidomimetic.
Jon Våbenø, Magnus Brisander, Tore Lejon, Kristina Luthman

J Org Chem· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis